Camptothecin-Based Regimens for Treatment of Ewing Sarcoma: Past Studies and Future Directions

Por Wagner, Lars
Publicado em 2011

Profile of veliparib and its potential in the treatment of solid tumors

Por Wagner, Lars M
Publicado no Onco Targets Ther (2015)

Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?

Por Wagner, Lars M.
Publicado no Clin Sarcoma Res (2015)

Management of recurrent Ewing sarcoma: challenges and approaches

Por Van Mater, David, Wagner, Lars
Publicado no Onco Targets Ther (2019)

Imaging of childhood urologic cancers: current approaches and new advances

Por Davis, Joseph T., Wagner, Lars M.
Publicado no Transl Androl Urol (2020)

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

Por Wagner, Lars M, Adams, Val R
Publicado no Onco Targets Ther (2017)

Assessment of Minimal Residual Disease in Ewing Sarcoma

Por Wagner, Lars M., Smolarek, Teresa A., Sumegi, Janos, Marmer, Daniel
Publicado em 2012

CTNI-75. A PILOT CLINICAL TRIAL OF OROTECAN (VAL-413), A NOVEL ORAL DOSAGE FORMULATION OF IRINOTECAN: IMPLICATIONS FOR PEDIATRIC BRAIN TUMORS

Por Brown, Dennis, Bacha, Jeffrey, Wagner, Lars, Leggas, Markos, Kanekal, Sarath, Lopez, Lorena, Sankar, Neil
Publicado no Neuro Oncol (2020)

National cancer database analysis of outcomes in pediatric glioblastoma

Por Liu, Meng, Thakkar, Jigisha P., Garcia, Catherine R., Dolecek, Therese A., Wagner, Lars M., Dressler, Emily Van Meter, Villano, John L.
Publicado no Cancer Med (2018)

Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study

Por Bagatell, Rochelle, London, Wendy B., Wagner, Lars M., Voss, Stephan D., Stewart, Clinton F., Maris, John M., Kretschmar, Cynthia, Cohn, Susan L.
Publicado em 2011

Phase II Study of Cixutumumab in Combination with Temsirolimus in Pediatric Patients and Young Adults with Recurrent or Refractory Sarcoma: A Report from the Children’s Oncology Gr...

Por Wagner, Lars M., Fouladi, Maryam, Ahmed, Atif, Krailo, Mark D., Weigel, Brenda, DuBois, Steven G., Doyle, L. Austin, Chen, Helen, Blaney, Susan M.
Publicado no Pediatr Blood Cancer (2014)

Phase I Trial of Two Schedules of Vincristine, Oral Irinotecan, and Temozolomide (VOIT) for Children with Relapsed or Refractory Solid Tumors: A Children's Oncology Group Phase I C...

Por Wagner, Lars M., Perentesis, John P., Reid, Joel M., Ames, Matthew M., Safgren, Stephanie L., Nelson, Marvin D., Ingle, Ashish M., Blaney, Susan M., Adamson, Peter C.
Publicado em 2010

Treatment pathway of bone sarcoma in children, adolescents, and young adults

Por Reed, Damon R., Hayashi, Masanori, Wagner, Lars, Binitie, Odion, Steppan, Diana A., Brohl, Andrew S., Shinohara, Eric T., Bridge, Julia A., Loeb, David M., Borinstein, Scott C., Isakoff, Michael S.
Publicado no Cancer (2017)

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy

Por Hilal, Talal, Nakazawa, Mary, Hodskins, Jacob, Villano, John L., Mathew, Aju, Goel, Guarav, Wagner, Lars, Arnold, Susanne M., DeSimone, Philip, Anthony, Lowell B., Hosein, Peter J.
Publicado no BMC Cancer (2017)

FEASIBILITY AND DOSE DISCOVERY ANALYSIS OF ZOLEDRONIC ACID WITH CONCURRENT CHEMOTHERAPY IN THE TREATMENT OF NEWLY DIAGNOSED METASTATIC OSTEOSARCOMA: A REPORT FROM THE CHILDEREN’S O...

Por Goldsby, Robert E., Fan, Timothy M., Villaluna, Doojduen, Wagner, Lars M., Isakoff, Michael S., Meyer, James, Randall, R. Lor, Lee, Sharon, Kim, Grace, Bernstein, Mark, Gorlick, Richard, Krailo, Mark, Marina, Neyssa
Publicado em 2013

Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation

Por Oesterheld, Javier E., Reed, Damon R., Setty, Bhuvana A., Isakoff, Michael S., Thompson, Patrick, Yin, Hong, Hayashi, Masanori, Loeb, David M., Smith, Tiffany, Makanji, Rikesh, Fridley, Brooke L., Wagner, Lars M.
Publicado no Pediatr Blood Cancer (2020)

A Pediatric Phase 1 Trial Of Vorinostat And Temozolomide In Relapsed Or Refractory Primary Brain Or Spinal Cord Tumors: A Children’s Oncology Group Phase 1 Consortium Study

Por Hummel, Trent R., Wagner, Lars, Ahern, Charlotte, Fouladi, Maryam, Reid, Joel M., McGovern, Renee M., Ames, Matthew M., Gilbertson, Richard J., Horton, Terzah, Ingle, Ashish M., Weigel, Brenda, Blaney, Susan M.
Publicado em 2013

Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study

Por Fouladi, Maryam, Stewart, Clinton F., Olson, James, Wagner, Lars M., Onar-Thomas, Arzu, Kocak, Mehmet, Packer, Roger J., Goldman, Stewart, Gururangan, Sridharan, Gajjar, Amar, Demuth, Tim, Kun, Larry E., Boyett, James M., Gilbertson, Richard J.
Publicado em 2011

An evolutionary framework for treating pediatric sarcomas

Por Reed, Damon R., Metts, Jonathan, Pressley, Mariyah, Fridley, Brooke L., Hayashi, Masanori, Isakoff, Michael S., Loeb, David M., Makanji, Rikesh, Roberts, Ryan D., Trucco, Matteo, Wagner, Lars M., Alexandrow, Mark G., Gatenby, Robert A., Brown, Joel S.
Publicado no Cancer (2020)

Phase I Trial of Oral Irinotecan and Temozolomide for Children With Relapsed High-Risk Neuroblastoma: A New Approach to Neuroblastoma Therapy Consortium Study

Por Wagner, Lars M., Villablanca, Judith G., Stewart, Clinton F., Crews, Kristine R., Groshen, Susan, Reynolds, C. Patrick, Park, Julie R., Maris, John M., Hawkins, Randall A., Daldrup-Link, Heike E., Jackson, Hollie A., Matthay, Katherine K.
Publicado em 2009